Genmab — November 2023
-
Tisotumab Vedotin for Metastatic Cervical Cancer: Results From ESMO 2023 With Brian Slomovitz, MD https://oncdata.com/news/tisotumab-vedotin-for-metastatic-cervical-cancer-results-from-esmo-2023-with-brian-slomovitz-md-1 -nice, easy to read explanation
-
Collaboration revenue
was DKK 332 million in 2022 compared to
DKK 20 million in 2021. The increase of DKK
312 million was primarily driven by increased
sales of Tivdak and also includes a one-off
payment due from Seagen of DKK 112 million
(approximately USD 15 million) which reflects
Genmab’s share (50%) of payments received by
Seagen in connection with the sublicense of its
rights to develop and commercialize tisotumab
vedotin in China to Zai -
Godmorgen
-
En anden ting markedet / analytikerne nok overser/glemmer er at Genmab stadig pumper penge i tivdaq men som salget stiger og udgifter til kliniske studier falder vil profit margen stige fra år til år fremadrettet. Anatytikerne ser alt for negativt på her og nu omkostninger som jo er investering i fremtiden.
-
-
Novo har startet et fase 1 studie op med et antistof rettet mod cancer. Ehh okay. Har de en ny aftale med Genmab eller hvor kommer det antistof fra. Nogen der ved det?
-
Hov ikke cancer. CV
-
De har startet et andet fase 1 op med nyt stof mod cancer. In September 2023, Novo Nordisk initiated a phase 1 trial with STAT3, an immuno-oncology target with the goal of
silencing STAT3 in tumor-associated immune cells.
andet cancer -
Det er via deres 2021 opkøb af Dicerna og deres Rnai platform. Så novo er nu med i Rnai feltet
-
Cervical cancer drug raises survival rate by 30% compared to chemotherapy: ‘Game-changer’
TIVDAK's bombshell results in phase 3 trial change the 'standard of care,' says lead researcher https://www.foxnews.com/health/cervical-cancer-drug-increased-survival-rate-30-percent-chemotherapy-game-changer
Hello! It looks like you're interested in this conversation, but you don't have an account yet.
Getting fed up of having to scroll through the same posts each visit? When you register for an account, you'll always come back to exactly where you were before, and choose to be notified of new replies (either via email, or push notification). You'll also be able to save bookmarks and upvote posts to show your appreciation to other community members.
With your input, this post could be even better 💗
Tilmeld Log ind